(Q37424189)

20 August 2017

1 reference

title

Intravenous proton pump inhibitors: an evidence-based review of their use in gastrointestinal disorders (English)

1 reference

20 August 2017

Marc Bardou

1

1 reference

20 August 2017

Janet Martin

series ordinal

2

1 reference

20 August 2017

Alan Barkun

series ordinal

3

1 reference

20 August 2017

1 January 2009

1 reference

20 August 2017

1 reference

20 August 2017

69

1 reference

20 August 2017

435-448

1 reference

20 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200969040-00004

20 August 2017

0 references

cites work

Proton-pump inhibitor use and the risk for community-acquired pneumonia

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200969040-00004

Lansoprazole regimens that sustain intragastric pH > 6.0: an evaluation of intermittent oral and continuous intravenous infusion dosages

21 January 2018

1 reference

12 December 2020

Randomized trial comparing pantoprazole infusion, bolus and no treatment on gastric pH and recurrent bleeding in peptic ulcers

1 reference

12 December 2020

A comparison of rabeprazole, lansoprazole, and ranitidine for improving preoperative gastric fluid property in adults undergoing elective surgery.

1 reference

12 December 2020

Clinically significant gastrointestinal bleeding in critically ill patients with and without stress-ulcer prophylaxis

1 reference

12 December 2020

Medical treatments in the short term management of reflux oesophagitis

1 reference

12 December 2020

Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients

1 reference

12 December 2020

Esomeprazole versus pantoprazole for healing erosive oesophagitis.

1 reference

12 December 2020

Proton Pump Inhibitor Use and Risk of Hip Fractures in Patients without Major Risk Factors

1 reference

12 December 2020

Gastrointestinal bleeding in the hospitalized patient: a case-control study to assess risk factors, causes, and outcome

1 reference

12 December 2020

Occurrence of community-acquired respiratory tract infection in patients receiving esomeprazole: retrospective analysis of adverse events in 31 clinical trials

1 reference

12 December 2020

Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis

1 reference

12 December 2020

A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy

1 reference

12 December 2020

Differences in binding properties of two proton pump inhibitors on the gastric H+,K+-ATPase in vivo

1 reference

12 December 2020

Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

1 reference

12 December 2020

Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study.

1 reference

12 December 2020

Symptomatic gastroesophageal reflux in acutely hospitalized patients.

1 reference

12 December 2020

Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers

1 reference

12 December 2020

Increase in vertebral fracture risk in postmenopausal women using omeprazole

1 reference

12 December 2020

Intragastric pH with oral vs intravenous bolus plus infusion proton-pump inhibitor therapy in patients with bleeding ulcers

1 reference

12 December 2020

Oral esomeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects

1 reference

12 December 2020

Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.

1 reference

12 December 2020

Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial

1 reference

12 December 2020

Famotidine versus pantoprazole for preventing bleeding in the upper gastrointestinal tract of critically ill patients receiving mechanical ventilation.

1 reference

12 December 2020

Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study

1 reference

12 December 2020

Review article: acid suppression in non-variceal acute upper gastrointestinal bleeding.

1 reference

12 December 2020

Effect of intravenous esomeprazole 40 mg and pantoprazole 40 mg on intragastric pH in healthy subjects. A prospective, open, randomised, two-way cross-over comparative study

1 reference

12 December 2020

Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study

1 reference

12 December 2020

The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients

1 reference

12 December 2020

Acid-suppressive medications and risk of bone loss and fracture in older adults

1 reference

12 December 2020

Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage

1 reference

12 December 2020

Appropriate acid suppression for the management of gastro-oesophageal reflux disease

1 reference

12 December 2020

Esomeprazole 40 mg i.v. provides faster and more effective intragastric acid control than pantoprazole 40 mg i.v.: results of a randomized study

1 reference

12 December 2020

Comparison of the enteral and intravenous lansoprazole pharmacodynamic responses in critically ill patients

1 reference

12 December 2020

High- versus low-dose proton pump inhibitors after endoscopic hemostasis in patients with peptic ulcer bleeding: a multicentre, randomized study.

1 reference

12 December 2020

Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: a series of meta-analyses

1 reference

12 December 2020

Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group

1 reference

12 December 2020

Intravenous esomeprazole 40 mg vs. intravenous lansoprazole 30 mg for controlling intragastric acidity in healthy adults.

1 reference

12 December 2020

Intravenous Esomeprazole 40mg is Effective for the Control of Intragastric Acid Levels Whether Given as a 3-Minute Injection or a 30-Minute Infusion.

1 reference

12 December 2020

High-dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost-effectiveness analysis.

1 reference

12 December 2020

Effect of frequent dosing of an oral proton pump inhibitor on intragastric pH

1 reference

12 December 2020

Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit

1 reference

12 December 2020

Comparison of omeprazole and ranitidine for stress ulcer prophylaxis.

1 reference

12 December 2020

A pilot study of efficacy and safety of continuous intravenous infusion of pantoprazole in the treatment of severe erosive esophagitis

1 reference

12 December 2020

Acid suppression in a critical care environment: state of the art and beyond

1 reference

12 December 2020

Cost-effectiveness analysis of high-dose omeprazole infusion before endoscopy for patients with upper-GI bleeding.

1 reference

12 December 2020

The effect of regular and high doses of omeprazole on the intragastric acidity in patients with bleeding peptic ulcer treated endoscopically: a clinical trial with continuous intragastric pH monitoring

1 reference

12 December 2020

Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients

1 reference

12 December 2020

Intravenous proton pump inhibitors.

1 reference

12 December 2020

Management of acute bleeding from a peptic ulcer

1 reference

12 December 2020

Omeprazole before endoscopy in patients with gastrointestinal bleeding

1 reference

12 December 2020

Meta-analysis: proton-pump inhibition in high-risk patients with acute peptic ulcer bleeding

1 reference

12 December 2020

Effect of intravenous application of esomeprazole 40 mg versus pantoprazole 40 mg on 24-hour intragastric pH in healthy adults

1 reference

12 December 2020

Intravenous esomeprazole (40 mg and 20 mg) inhibits gastric acid secretion as effectively as oral esomeprazole: results of two randomized clinical studies

1 reference

12 December 2020

Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms

1 reference

12 December 2020

Intermittent intravenous pantoprazole and continuous cimetidine infusion: effect on gastric pH control in critically ill patients at risk of developing stress-related mucosal disease

1 reference

12 December 2020

The relationship between the control of pH and healing and symptom relief in gastro-oesophageal reflux disease

1 reference

12 December 2020

Esomeprazole 40 mg administered intravenously has similar safety and efficacy profiles to the oral formulation in patients with erosive esophagitis

1 reference

12 December 2020

Intravenous pantoprazole as initial treatment in patients with gastroesophageal reflux disease and a history of erosive esophagitis: a randomized clinical trial.

1 reference

12 December 2020

Epidemiology and natural history of gastro-oesophageal reflux disease

1 reference

12 December 2020

Optimizing the intragastric pH as a supportive therapy in upper GI bleeding

1 reference

12 December 2020

High-dose pantoprazole continuous infusion is superior to somatostatin after endoscopic hemostasis in patients with peptic ulcer bleeding

1 reference

12 December 2020

Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding

1 reference

12 December 2020

Proton pump inhibitor therapy for peptic ulcer bleeding: Cochrane collaboration meta-analysis of randomized controlled trials

1 reference

12 December 2020

Cost-effectiveness of proton-pump inhibition before endoscopy in upper gastrointestinal bleeding

1 reference

12 December 2020

The Effect of Intravenous Pantoprazole and Ranitidine for Improving Preoperative Gastric Fluid Properties in Adults Undergoing Elective Surgery

1 reference

12 December 2020

Omeprazole versus ranitidine plus somatostatin in the treatment of severe gastroduodenal bleeding: a prospective, randomized, controlled trial

1 reference

12 December 2020

The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting

1 reference

12 December 2020

Long-term proton pump inhibitor therapy and risk of hip fracture

1 reference

12 December 2020

10.2165/00003495-200969040-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

20 August 2017

0 references

1 reference